A team of scientists has made valuable progress toward creating clinical-grade cells for treatment of bone disease and injury. In their study, the team identified two types of growth media that could support effective expansion of mesenchymal progenitor (MP) cells from stem cells in a clinically compatible, Good Manufacturing Practice (GMP) setting.
About The Author
28 November, 2018
11 July, 2018
Our Facebook Page
amniotic stem cells Biology Biotech california stem cells California Stem Cell Treatment Center Cancer Cell Surgical Network CIRM CRISPR Daily fat stem cells fda FDA stem cells Health iPS cells Jeanne Loring Kristin Comella Leigh Turner Liveyon Medical research Pharma Research review Science Society stem cell clinic stem cell clinics stem cell law stem cell lawsuit Stem Cell News Stem Cell Research Stem cells Stem Cell Therapy stem cell treatment stem cell treatment cost Stemgenex SYN The Nutshell Top Story U.S. Stem Cell Inc Uncategorized USRM US Stem Cell Viacyte World news